{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:33:52Z","timestamp":1791178432263,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1136\/ard.2008.091967","type":"journal-article","created":{"date-parts":[[2008,7,29]],"date-time":"2008-07-29T00:24:20Z","timestamp":1217291060000},"page":"546-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis"],"prefix":"10.1016","volume":"68","author":[{"given":"S S","family":"Jick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I B","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2008.091967_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.091967_bib2","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.091967_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial.","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.091967_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease.","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.091967_bib5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(98)05917-0","article-title":"Inhibition of proinflammatory cytokine production by pravastatin.","volume":"353","author":"Rosenson","year":"1999","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.091967_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/01.ATV.21.1.3","article-title":"New evidence for beneficial effects of statins unrelated to lipid lowering.","volume":"21","author":"Palinski","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1136\/ard.2008.091967_bib7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization.","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"key":"10.1136\/ard.2008.091967_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation.","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.091967_bib9","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/01.CIR.96.5.1398","article-title":"Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial.","volume":"96","author":"Wenke","year":"1997","journal-title":"Circulation"},{"issue":"21 suppl 1","key":"10.1136\/ard.2008.091967_bib10","first-page":"II15","article-title":"Statins as immunomodulatory agents.","volume":"109","author":"Mach","year":"2004","journal-title":"Circulation"},{"key":"10.1136\/ard.2008.091967_bib11","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.healun.2005.02.009","article-title":"Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.","volume":"24","author":"Kobashigawa","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1136\/ard.2008.091967_bib12","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia.","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.091967_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1749-6632.2000.tb05571.x","article-title":"A perspective on inflammation in Alzheimer\u2019s disease.","volume":"924","author":"Rogers","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1136\/ard.2008.091967_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/87839","article-title":"Inflammation and Alzheimer disease: the good, the bad, and the ugly.","volume":"7","author":"Weninger","year":"2001","journal-title":"Nat Med"},{"key":"10.1136\/ard.2008.091967_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/01.ATV.21.1.115","article-title":"Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering.","volume":"21","author":"Sparrow","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1136\/ard.2008.091967_bib16","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.170.3.1524","article-title":"A novel anti-inflammatory role for simvastatin in inflammatory arthritis.","volume":"170","author":"Leung","year":"2003","journal-title":"J Immunol"},{"key":"10.1136\/ard.2008.091967_bib17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejphar.2005.05.005","article-title":"Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis.","volume":"516","author":"Barsante","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1136\/ard.2008.091967_bib18","first-page":"463","article-title":"Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis.","volume":"33","author":"Yokota","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.091967_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ndt\/gfi224","article-title":"In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.","volume":"21","author":"Panichi","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/ard.2008.091967_bib20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00296-006-0270-9","article-title":"Effects of pravastatin in murine collagen-induced arthritis.","volume":"27","author":"Yamagata","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.2008.091967_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/FJC.0b013e31802ba4ec","article-title":"Impact of simvastatin and losartan on antiinflammatory effect: in vitro study.","volume":"49","author":"Chang","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1136\/ard.2008.091967_bib22","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomized placebo-controlled trial.","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.091967_bib23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2125.1998.00701.x","article-title":"Use of the UK General Practice Research Database for pharmacoepidemiology.","volume":"45","author":"Garc\u00eda Rodr\u00edguez","year":"1998","journal-title":"Br J Clin Pharm"},{"key":"10.1136\/ard.2008.091967_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/pds.2630010607","article-title":"Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom.","volume":"1","author":"Jick","year":"1992","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1136\/ard.2008.091967_bib25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0049-0172(92)90017-8","article-title":"Dyslipoproteinemia in the course of active rheumatoid arthritis.","volume":"22","author":"Lazarevic","year":"1992","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2008.091967_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/ard.56.6.341","article-title":"Dyslipidemia and rheumatoid arthritis.","volume":"56","author":"Situnayake","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.091967_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/ard.57.3.175","article-title":"Lipid profiles in patients with rheumatoid arthritis.","volume":"57","author":"Kavanaugh","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.091967_bib28","first-page":"1746","article-title":"Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.","volume":"31","author":"Yoo","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.091967_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00296-004-0438-0","article-title":"Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation.","volume":"25","author":"Dursunoglu","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.2008.091967_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/ard.2006.051672","article-title":"Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis.","volume":"66","author":"van Halm","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.091967_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1139\/H07-036","article-title":"Lipid mediators in membrane rafts are important determinants of human health and disease.","volume":"32","author":"Ma","year":"2007","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1136\/ard.2008.091967_bib32","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(04)16205-3","article-title":"Oral simvastatin treatment in relapsing-remitting multiple sclerosis.","volume":"363","author":"Vollmer","year":"2004","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.091967_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.103.3.357","article-title":"Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.","volume":"103","author":"Freeman","year":"2001","journal-title":"Circulation"},{"key":"10.1136\/ard.2008.091967_bib34","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/00007890-199605270-00010","article-title":"The effect of pravastatin on acute rejection after kidney transplantation\u2014a pilot study.","volume":"61","author":"Katznelson","year":"1996","journal-title":"Transplantation"},{"key":"10.1136\/ard.2008.091967_bib35","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0041-1345(00)00921-0","article-title":"Comparison of the effects of simvastatin and pravastatin on acute rejection episodes in renal transplant patients.","volume":"32","author":"Tuncer","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1136\/ard.2008.091967_bib36","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1056\/NEJMoa043792","article-title":"Statins and the risk of colorectal cancer.","volume":"352","author":"Poynter","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.091967_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.21521","article-title":"Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy?","volume":"54","author":"Abeles","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.091967_bib38","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/01.ATV.0000038754.39483.CD","article-title":"Unraveling pleiotropic effects of statins on plaque rupture.","volume":"22","author":"Palinski","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1136\/ard.2008.091967_bib39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2125.2003.01724.x","article-title":"Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation.","volume":"55","author":"Yang","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1136\/ard.2008.091967_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001648-199007000-00005","article-title":"Reproductive factors, smoking, and the risk for rheumatoid arthritis.","volume":"1","author":"Hernandez Avila","year":"1990","journal-title":"Epidemiology"},{"key":"10.1136\/ard.2008.091967_bib41","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/art.1780401106","article-title":"Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case\u2013control study in Norfolk, England.","volume":"40","author":"Symmons","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.091967_bib42","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/ard.62.9.835","article-title":"Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases.","volume":"62","author":"Stolt","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.091967_bib43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/03009740310004748","article-title":"Aetiological factors of importance for the development of rheumatoid arthritis.","volume":"33","author":"Olsson","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2008.091967_bib44","doi-asserted-by":"crossref","first-page":"503.e1","DOI":"10.1016\/j.amjmed.2005.09.053","article-title":"Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women.","volume":"119","author":"Costenbader","year":"2006","journal-title":"Am J Med"},{"key":"10.1136\/ard.2008.091967_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/oxfordjournals.aje.a112878","article-title":"The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality.","volume":"111","author":"Linos","year":"1980","journal-title":"Am J Epidemiol"},{"key":"10.1136\/ard.2008.091967_bib46","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/art.1780341205","article-title":"Rheumatoid arthritis in women. Incidence rates in group health cooperative, Seattle, Washington, 1987\u20131989.","volume":"34","author":"Dugowson","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.091967_bib47","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/art.1780361207","article-title":"Incidence of rheumatoid arthritis in central Massachusetts.","volume":"36","author":"Chan","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.091967_bib48","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/art.1780370606","article-title":"The lag time between onset of symptoms and diagnosis of rheumatoid arthritis.","volume":"37","author":"Chan","year":"1994","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724425612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724425612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2008.091967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T05:16:46Z","timestamp":1737263806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724425612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0003496724425612"],"URL":"https:\/\/doi.org\/10.1136\/ard.2008.091967","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2008.091967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 2009 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}